CLINICAL_TRIALS
trial_result
· 2022-11-22
Clinical Trial Update: SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 clinical trial update evaluating SU11248 as consolidation after response to taxanes in metastatic breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED